首页> 外国专利> METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY COMBINATION OF TRIMETAZIDINE AND L-ARGININE IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY

METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY COMBINATION OF TRIMETAZIDINE AND L-ARGININE IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY

机译:曲美他嗪与L-精氨酸联用纠正内皮细胞功能异常的方法,改善L-名字引起的一氧化氮缺乏

摘要

FIELD: medicine.;SUBSTANCE: endothelial dysfunction correction is ensured by simulating endothelial dysfunction by the intraperitoneal introduction to laboratory male rats Wistar of N-nitro-L-arginine methyl ether 25 mg/kg daily for 7 days. A development degree of endothelial dysfunction is estimated by the relation of endothelium-independent and endothelium-dependent vasodilation indicators. The endothelial dysfunction correction is ensured by the intragastric introduction of trimetazidine 6 mg/kg and the intraperitoneal introduction of L-arginine 200 mg/kg.;EFFECT: method provides activation of the L-NAME-induced endothelial dysfunction correction ensured by the introduction of a specific combination of the pharmacological preparations promoting the improvement of endothelial vasorelaxation properties.;2 tbl, 1 ex
机译:领域:医学;研究对象:通过向实验雄性大鼠Wistar腹膜内引入N-硝基-L-精氨酸甲基醚25 mg / kg每天7天来模拟内皮功能障碍,从而确保内皮功能障碍的矫正。通过内皮依赖性和内皮依赖性血管舒张指标的关系来估计内皮功能障碍的发展程度。通过在胃内引入曲美他嗪6 mg / kg和在腹膜内引入L-精氨酸200 mg / kg来确保内皮功能障碍的纠正;效果:该方法通过引入L-NAME来确保激活由L-NAME引起的内皮功能障碍的纠正。促进内皮血管舒张特性改善的药理制剂的特定组合。; 2 tbl,1 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号